Fair Value Measurements (Tables)

9 Months Ended

Nov. 02, 2024

Fair Value Disclosures [Abstract]

Schedule of fair values of financial instruments

The fair value of the Company’s financial instruments are as follows:

($000)	November 2, 2024		February 3, 2024		October 28, 2023
Cash and cash equivalents (Level 1)	$	4,349,262	$	4,872,446	$	4,499,497
Restricted cash and cash equivalents (Level 1)	$	65,396	$	62,995	$	62,511

Schedule of fair value of assets and liabilities

The fair value measurement for funds with quoted market prices in active markets (Level 1) are as follows:

($000)	November 2, 2024		February 3, 2024		October 28, 2023
Nonqualified deferred compensation program (Level 1)	$	189,522	$	165,582	$	145,003